From a historical point of view, tolerance was first described in mid-1911, long before the description of its mechanisms. Today it is characterized by local hyperactivity with proliferation of regulatory T and B cells, production of anti-inflammatory cytokines, secretory IgA and stimulation to the microbiota for the production of short chain fatty acids, concomitant with systemic hyporesponsiveness with low IgG and IgE antibodies production. Perhaps due to these characteristics, the induction of immunological tolerance and in particular the mucosal tolerance (oral) has attracted considerable attention as a therapeutic possibility, especially for the treatment of food sensitivities. All the strategies used for intestinal modulation are also considered important for the recovery of mucosal tolerance and, to some extent, have been applied in practice, even though in an empirical or intuitive way, for many years.